Whereas more patients with FGF23 levels below or at the expected range received ACE inhibitors (47.4% versus 38.5%) and about the same proportion received vitamin D analogs (31.6% versus 30.8%), this did not reach statistical significance.
← all excerpts
Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.
1
—
—